Determinants of direct and indirect costs in anorexia nervosa.

About this resource

OBJECTIVE: To estimate direct and indirect costs of anorexia nervosa (AN), and to identify cost determinants. METHODS: In a subsample (n = 225) of the ANTOP trial (Anorexia Nervosa Treatment of OutPatients) health care utilization and productivity losses were assessed at baseline for the previous 3 months and monetarily valued. Included were females aged 18 years and older diagnosed with AN or subsyndromal AN, and a body mass index (BMI) between 15 and 18.5 kg/m(2) . To account for missing data multiple imputation was employed. Cost determinants were derived from generalized linear models with gamma distribution and log link function. RESULTS: Mean 3-months costs per patient amounted to €5,866 (SE = €576). The largest share of costs (€3,374) resulted from hospitalizations. Determinants of direct costs were analyzed separately for those with hospitalizations for AN, and those without. In the group only treated as outpatients, participants with binge/purge subtype, and those diseased for more than 6 years had higher costs. Moreover, costs were increased in patients with a comorbid mental disorder. In the group with hospitalizations, direct costs increased with BMI. BMI was measured at the end of the observation period, indicating that longer duration of treatment yielded higher weight gain. Indirect costs were not significantly associated with any disease-related characteristic. DISCUSSION: Costs resulting from health care utilization and productivity loss are substantial, although the sample studied had not received sufficient treatment. Future research should analyze the development of costs over time.

AuthorStuhldreher N., Konnopka A., Konig H.-H., Wild B., Zipfel S., Herzog W.
JournalInternational Journal of Eating Disorders
Volume48(1):139-46
Year2015

See also

COERCIVE TREATMENT OPTIONS FOR ANOREXIA UNDER THE MENTAL HEALTH AND GUARDIANSHIP ACTS

This article outlines the voluntary and coercive treatment of eating disorders under both the Mental Health Act 2007 and the Guardianship Act 1987.

Read more

Mandometer treatment not superior to treatment as usual for anorexia nervosa

OBJECTIVE: A comparison of the efficacy of a novel treatment method for anorexia nervosa (AN), the Mandometer treatment (MT), with treatment as usual (TAU).

Read more

Puberty as a critical risk period for eating disorders: A review of human and animal studies

This article is part of a Special Issue “Puberty and Adolescence”.

Read more

Comparing effects: a reanalysis of two studies on season of birth bias in anorexia nervosa

BACKGROUND: Outcomes from studies on season of birth bias in eating disorders have been inconsistent.

Read more

Help us improve!

Give us feedback!

We will continue throughout 2019 to update and improve the NEDC website and welcome any feedback you may have on the site.

Provide feedback